UWM
JAZZ icon

Urban Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Urban Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$17K Buy
+107
New +$16.5K 0.06% 158

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Urban Wealth Management's JAZZ Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2022: 107 shares worth $17K. The stake represents 0.06% of the portfolio and ranks #158 among its holdings.

468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Urban Wealth Management held 107 shares of Jazz Pharmaceuticals worth $17K as of Q2 2022.
  • Jazz Pharmaceuticals was a new Urban Wealth Management position in Q2 2022.
  • Jazz Pharmaceuticals made up 0.06% of Urban Wealth Management's portfolio in Q2 2022, its #158 holding.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.